Insider Trading Activity - UBS Oncology Impact Fund L.P.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for UBS Oncology Impact Fund L.P.

Goto Prev, 0, 1

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2021-04-09 Sale	2021-04-13 4:13 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	30,928	$21.9	$677,357	7,105,800 (Indirect)	View
2021-04-07 Sale	2021-04-09 4:47 pm	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC 10% Owner	41,982	$30.99	$1,300,850	6,020,238 (Indirect)	View
2021-01-12 Purchase	2021-01-14 5:54 pm	Cullinan Management Inc.	CGEM	UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner	300,000	$21	$6,300,000	7,913,887 (Direct)	View
2020-10-06 Purchase	2020-10-08 6:26 pm	Oncorus Inc.	ONCR	UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner	151,224	$15	$2,268,360	2,377,025 (Direct)	View
2020-07-28 Purchase	2020-07-30 08:00 am	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. Director 10% Owner	320,000	$19	$6,080,000	2,355,557 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2021-04-07 Other	2021-04-09 4:47 pm	N/A N/A	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC 10% Owner	15,670	$0	6,020,238 (Indirect)	View
2021-01-12 Conversion	2021-01-14 5:54 pm	N/A N/A	Cullinan Management Inc.	CGEM	UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner	7,613,887	$0	7,913,887 (Direct)	View
Ownership(A)	2021-01-14 5:49 pm	N/A N/A	Cullinan Management Inc.	CGEM	UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner	0	$0	7,613,887 (Direct)	View
Ownership	2021-01-07 8:37 pm	N/A N/A	Cullinan Management Inc.	CGEM	UBS Oncology Impact Fund L.P. 10% Owner	0	$0	7,613,887 (Direct)	View
2020-10-06 Conversion	2020-10-08 6:26 pm	N/A N/A	Oncorus Inc.	ONCR	UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner	2,225,801	$0	2,377,025 (Direct)	View
Ownership	2020-10-01 7:23 pm	N/A N/A	Oncorus Inc.	ONCR	UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner	0	$0	2,252,947 (Direct)	View
2020-07-28 Conversion	2020-07-30 08:00 am	N/A N/A	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. Director 10% Owner	23,558,112	$0	2,355,557 (Indirect)	View
Ownership	2020-07-23 7:22 pm	N/A N/A	iTeos Therapeutics Inc.	ITOS	GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. Director 10% Owner	0	$0	5,742,220 (Indirect)	View

(A) Indicate amendment filing.

Goto Prev, 0, 1

Insider Trading & Ownership - UBS Oncology Impact Fund L.P.